Ali Khamesipour-CV

13-15 May 1998, Isfahan, Iran.Phase III efficacy trial of multiple doses of autoclaved L. major plus BCG. 1 st Product Development Team meetingon leishmaniasis vaccine, TDR/WHO, 24-27 September 1998, Quito, Ecuador.Prevention of cutaneous leishmaniasis and progress in vaccine development. 4 th Intern. Cong. in Dermat. 8-10 Oct.1997 Tehran, Iran.Safety and immunogenicity of three injections of autoclaved L. major in leishmanin negative and positive schoolchildren.1 st World Congress on leishmaniasis, May 5-9, 1997, Istanbul, TurkeyComparison of three types of leishmanins: standard, autoclaved and freeze thawed. 1 st World Congress onleishmaniasis, May 5-9, 1997 Istanbul, TurkeyPhase I-II safety and immunogenicity of multiple doses of autoclaved L. major plus BCG in children. WHO/TDRSteering committee meeting, May 2-4, 1997 Istanbul, TurkeyComparison of Specificity and Sensitivity of Two Types of Leishmanin (autoclaved L. major and thimerosal treatedL. major). The clinical trials of killed Leishmania major vaccine. Amman, Jordan April 15-16, 1996.Induction of partial protection in susceptible Balb/c mice via subcutaneous route of immunization. The clinical trialsof killed Leishmania major vaccine.Amman, Jordan April 15-16, 1996.Induction of partial protection in susceptible Balb/c mice via subcutaneous route of immunization. The clinical trialsof killed Leishmania major vaccine.Amman, Jordan April 15-16, 1996.AbstractsKhamesipour A, Khatami AR, Eskandari SE, Ghoorchi MH, Bahrami M, Gorouhi F, Javadi A, Nassiri-Kashani M,Firooz AR, Sharifi I, Fekri AR, Dowlati Y. Randomized open-labeled controlled clinical trial on efficacy of oralmiltefosine in comparison with meglumine antimoniate in the treatment of acute Anthroponotic CutaneousLeishmaniasis (ACL).4 th World Congress on Leishmaniasis, Lucknow, India, 3-7 February 2009.Sharifi I, Aflatoonian MR, Fekri AR, Khamesipour A, Cutaneous leishmaniasis in Bam: Five years before and afterthe earthquake. 4 th World Congress on Leishmaniasis, Lucknow, India, 3-7 February 2009.Khamesipour A, Khatami AR, Eskandari SE, Ghoorchi MH, Bahrami M, Gorouhi F, Javadi A, Nassiri-Kashani M,Firooz AR, Sharifi I, Fekri AR, Jalali M, Dowlati Y. Comparison of the efficacy of weekly intralesional injections ofmeglumine antimoniate with twice a week injections in the of acute anthroponotic cutaneous leishmaniasistreatment.4 th World Congress on Leishmaniasis, Lucknow, India, 3-7 February 2009.Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Evaluation of immune response and protectionextent against leishmaniasis in BALB/c mice immunized with liposomal rgp63: The role of liposome size. 4 th WorldCong. Leishmaniasis, Lucknow, India, 3-7 February 2009.Hejazi SH, Zia Jahromi N, Bandehpour M, Eslami G, Salehi R, khamesipour A, Kazemi B.Gene cloning of Iranian Leishmania major mannose-1-phosphate guanyltransferase. 4 th World Congress onLeishmaniasis, Lucknow, India, 3-7 February 2009.Jaafari MR, Bavarsad N, Fazly Bazzaz BS, Samiei A, Soroush D, Ghorbani S, Lotfi heravi MM, Khamesipour A.The effect of Topical liposomes containing Paromomycin Sulfate (PM) in the treatment of L. major infected Balb/cmice 4 th World Congress on Leishmaniasis, Lucknow, India, 3-7 February 2009.Jaafari MR, Badiee, Khamesipour A, Samiei A, Soroush D, Tavassoti Kheiri M, Barkhordari F, Mahboudi F,Immunization of BALB/c mice against Leishmaniasis using LPD Nanoparticles Containing rgp63 and rLmaCINPrepared with CpG Oligodeoxynucleotides. 4 th World Congress on Leishmaniasis, Lucknow, India, 3-7 February2009.Sharifi I, Shokri A, Khamesipour A, Fasihi Harandi M. The synergitic effect of verapamil on in vitro susceptibility4